| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307447 | Schizophrenia Research | 2014 | 5 Pages |
Abstract
These longitudinal data are in line with previous reports from cross-sectional studies. The excitability changes induced by three-week intake of quetiapine in acute psychotic patients confirm the notion that neuroleptic treatment is associated with an increase in CSP.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Elmar Frank, Michael Landgrebe, Timm B. Poeppl, Martin Schecklmann, Peter M. Kreuzer, Julia Prasser, Rainer Rupprecht, Peter Eichhammer, Göran Hajak, Berthold Langguth,